CDKN2A and renal cell adenocarcinoma: The findings extend the correlation of CDKN2A loss with decreased survival in ccRCC and papillary RCC (pRCC) to chromophore RCC (chRCC) and demonstrate that mutation metabolism is associated with negative predictors in patients with ccRCC or metabolic-separated chRCC [103].